Recent trends in cancer drug resistance reversal strategies using nanoparticles
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent trends in cancer drug resistance reversal strategies using nanoparticles
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 9, Issue 3, Pages 287-301
Publisher
Informa Healthcare
Online
2012-02-20
DOI
10.1517/17425247.2012.665365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From sentencing to execution – the processes of apoptosis
- (2015) Kelly L. Moffitt et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Squalene Based Nanocomposites: A New Platform for the Design of Multifunctional Pharmaceutical Theragnostics
- (2011) José L. Arias et al. ACS Nano
- Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7BThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process.
- (2011) Oleg Y. Dmitriev Biochemistry and Cell Biology
- Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles
- (2011) Ling Xiao et al. BIOMATERIALS
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- MicroRNAs as new therapeutic targets and tools in cancer
- (2011) Paolo Gandellini et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
- (2011) Zhe-Sheng Chen et al. FEBS Journal
- Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes
- (2011) Niravkumar R. Patel et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ultrasound Mediated Drug-Loaded Nanoparticles Crossing Cell Membranes as a New Strategy to Reverse Cancer Multidrug Resistance
- (2011) Haijun Zhang et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
- (2011) Phong Trang et al. MOLECULAR THERAPY
- Silencing microRNA by interfering nanoparticles in mice
- (2011) Jie Su et al. NUCLEIC ACIDS RESEARCH
- Combination of Hyaluronic Acid Hydrogel Scaffold and PLGA Microspheres for Supporting Survival of Neural Stem Cells
- (2011) Ying Wang et al. PHARMACEUTICAL RESEARCH
- Vascular Endoluminal Delivery of Mesenchymal Stem Cells Using Acoustic Radiation Force
- (2011) Catalin Toma et al. TISSUE ENGINEERING PART A
- Novel Nanoassemblies Composed of Squalenoyl−Paclitaxel Derivatives: Synthesis, Characterization, and Biological Evaluation
- (2010) Franco Dosio et al. BIOCONJUGATE CHEMISTRY
- MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity
- (2010) Lei Shi et al. BRAIN RESEARCH
- Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells
- (2010) Meysam Abbasi et al. CANCER
- Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells
- (2010) Yaprak Dönmez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer Stem Cells in the Central Nervous System - A Critical Review
- (2010) L. Prestegarden et al. CANCER RESEARCH
- Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells
- (2010) Baoan Chen International Journal of Nanomedicine
- Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs
- (2010) Carlos M. Galmarini et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The future of aptamers in medicine
- (2010) M. Khati JOURNAL OF CLINICAL PATHOLOGY
- Development of PLGA Nanoparticles Simultaneously Loaded with Vincristine and Verapamil for Treatment of Hepatocellular Carcinoma
- (2010) Xiang Rong Song et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Reversion of Multidrug Resistance in Tumor By Biocompatible Nanomaterials
- (2010) H. Zhang et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Salinomycin in cancer: A new mission for an old agent
- (2010) Naujokat Molecular Medicine Reports
- Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer
- (2010) Yang Liu et al. MOLECULAR PHARMACEUTICS
- Targeted Delivery of Antisense Inhibitor of miRNA for Antiangiogenesis Therapy Using cRGD-Functionalized Nanoparticles
- (2010) Xi-Qiu Liu et al. MOLECULAR PHARMACEUTICS
- Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery To Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells
- (2010) Lara Milane et al. MOLECULAR PHARMACEUTICS
- Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as Temozolomide
- (2010) M. Eich et al. MOLECULAR PHARMACOLOGY
- Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
- (2010) Xiaowei Dong et al. Nanomedicine
- Tamoxifen-induced apoptosis of rat C6 glioma cells via PI3K/Akt, JNK and ERK activation
- (2010) Xie ONCOLOGY REPORTS
- Wild Type p53 Gene Sensitizes Rat C6 Glioma Cells to HSV-TK/ACV Treatment In Vitro and In Vivo
- (2010) Qiang Huang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer
- (2010) Fei Ren et al. PHARMACEUTICAL RESEARCH
- Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan
- (2010) V Boni et al. PHARMACOGENOMICS JOURNAL
- Role of symmetric and asymmetric division of stem cells in developing drug resistance
- (2010) C. Tomasetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting cancer cells with nucleic acid aptamers
- (2010) Laura Cerchia et al. TRENDS IN BIOTECHNOLOGY
- Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP
- (2009) X. Dong et al. CANCER RESEARCH
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma
- (2009) L. S. Mangala et al. CLINICAL CANCER RESEARCH
- Mechanism of Drug Sensitivity and Resistance in Melanoma
- (2009) Caterina La Porta CURRENT CANCER DRUG TARGETS
- 17 AAG for HSP90 Inhibition in Cancer – From Bench to Bedside
- (2009) Saad Usmani et al. CURRENT MOLECULAR MEDICINE
- Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles
- (2009) Xiang Rong Song et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
- (2009) Junfang Ji et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
- (2008) Yasunori Fujita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer
- (2008) Dawn P. G. Brown et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
- (2008) Helen M. Coley CANCER TREATMENT REVIEWS
- Multi-functional nanocarriers to overcome tumor drug resistance
- (2008) Lara S. Jabr-Milane et al. CANCER TREATMENT REVIEWS
- Characterization of a Novel Dithiocarbamate Glutathione Reductase Inhibitor and Its Use as a Tool to Modulate Intracellular Glutathione
- (2008) Teresa Seefeldt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
- (2008) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent progress in tumor pH targeting nanotechnology
- (2008) Eun Seong Lee et al. JOURNAL OF CONTROLLED RELEASE
- Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance
- (2008) Eun Seong Lee et al. JOURNAL OF CONTROLLED RELEASE
- Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells
- (2008) Alan Kambiz Fotoohi et al. LEUKEMIA & LYMPHOMA
- Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor- B, p53, bax, and p27 levels
- (2008) C. A. Tucker et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- The application of poly(N-isopropylacrylamide)-co-polystyrene nanofibers as an additive agent to facilitate the cellular uptake of an anticancer drug
- (2008) Min Song et al. NANOTECHNOLOGY
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
- (2008) Akin Akinc et al. NATURE BIOTECHNOLOGY
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
- (2008) S. Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNA Aptamer-targeted Inhibition of NF-κB Suppresses Non-small Cell Lung Cancer Resistance to Doxorubicin
- (2007) Jing Mi et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search